Amarin Corporation plc (AMRN)
NASDAQ: AMRN · Real-Time Price · USD
9.81
+0.34 (3.59%)
Apr 15, 2025, 4:00 PM EDT - Market closed

Amarin Corporation Market Cap

Amarin Corporation has a market cap or net worth of $203.16 million as of April 15, 2025. Its market cap has decreased by -44.46% in one year.

Market Cap
203.16M
Enterprise Value
-81.39M
1-Year Change
-44.46%
Ranking
Category
Stock Price
$9.81

Market Cap Chart

Since December 1, 1998, Amarin Corporation's market cap has decreased from $21.74B to $203.16M, a decrease of -99.07%. That is a compound annual growth rate of -16.23%.

History

DateMarket Cap% Change
Apr 14, 2025196.10M-1.70%
Dec 31, 2024199.50M-43.83%
Dec 29, 2023355.20M-27.30%
Dec 30, 2022488.60M-63.37%
Dec 31, 20211.33B-29.85%
Dec 31, 20201.90B-75.29%
Dec 31, 20197.70B83.89%
Dec 31, 20184.18B285.24%
Dec 29, 20171.09B31.56%
Dec 30, 2016825.60M138.20%
Dec 31, 2015346.60M102.57%
Dec 31, 2014171.10M-49.69%
Dec 31, 2013340.10M-72.00%
Dec 31, 20121.21B19.39%
Dec 30, 20111.02B26.09%
Dec 31, 2010806.80M1,984.75%
Dec 31, 200938.70M-99.59%
Dec 29, 20069.44B90.00%
Dec 30, 20054.97B-55.72%
Dec 31, 200411.22B75.97%
Dec 31, 20036.38B-61.40%
Dec 31, 200216.53B-77.03%
Dec 31, 200171.94B215.82%
Dec 29, 200022.78B15.79%
Dec 31, 199919.67B33.43%
View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 666.98B
UnitedHealth Group 535.11B
Johnson & Johnson 367.14B
AbbVie 314.27B
Novo Nordisk 283.15B
Abbott Laboratories 221.05B
AstraZeneca 202.51B
Novartis AG 200.23B
Market Cap Rankings